Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types

Je-Keun Rhee1,2, Yu Chae Jung3, Kyu Ryung Kim1,2

  • 1Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Cancer Immunology Research
|November 17, 2017
PubMed

Insights

Tumor purity significantly impacts cancer gene expression analysis. Accounting for non-tumor cell RNA is crucial for accurate cancer profiling and understanding immune gene expression correlations.

Area of Science:

  • Cancer genomics
  • Transcriptomics
  • Bioinformatics

Background:

  • Tumor specimens often contain non-tumor cells (immune, stromal), leading to impure RNA samples.
  • This impurity can interfere with the analysis of cancer gene expression profiles.
  • Understanding the impact of tumor purity is essential for accurate interpretation of cancer transcriptome data.

Purpose of the Study:

  • To systematically analyze the influence of tumor purity on gene expression profiles across various cancer types.
  • To investigate the relationship between tumor purity and immune gene expression, mutation burden, and molecular subtypes.
  • To highlight the importance of accounting for tumor purity in bulk transcriptome data analysis.

Main Methods:

  • Utilized gene expression profiles and tumor purity data from 7,794 tumor specimens across 21 tumor types from The Cancer Genome Atlas (TCGA).
  • Performed correlation analyses between tumor purity and gene expression, focusing on immune and oxidative phosphorylation pathways.
  • Examined the impact of tumor purity on gene clustering and the correlation of subtype-specific feature genes with purity.

Main Results:

  • Immunity-related genes were inversely correlated with tumor purity, while oxidative phosphorylation genes were positively correlated.
  • Immune cell infiltration and expression of immunotherapy-related genes showed a substantial inverse correlation with tumor purity.
  • Tumor purity significantly affected gene clustering and the correlation of molecular subtype markers (e.g., mesenchymal, classical) with purity.

Conclusions:

  • Tumor purity is a critical confounder in the analysis of bulk tumor transcriptome data.
  • Adjusting for tumor purity is necessary for accurate evaluation of gene expression markers, mutation burden correlations, and molecular taxonomy.
  • These findings underscore the need to consider tumor purity for robust cancer expression profiling and biomarker discovery.